Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2. During T-cell activation, the immune system uses different checkpoint pathways to maintain co-inhibitory and co-stimulatory signals. In COVID-19, expression of immune checkpoints (ICs) is one of the most important manifestations, in additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mterin, Mohammad A., Alsalman, Alhasan, Elkord, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008255/
https://www.ncbi.nlm.nih.gov/pubmed/35432324
http://dx.doi.org/10.3389/fimmu.2022.870283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008255/
https://www.ncbi.nlm.nih.gov/pubmed/35432324
http://dx.doi.org/10.3389/fimmu.2022.870283

Ejemplares similares